Sigma Labs Logo
Sigma Labs Logo
Sigma Labs Logo
Sigma Labs Logo
Sigma Labs Logo

Sigma Labs obtains exclusive patent rights for advanced dental implant technology

Nov. 15, 2013
Sigma Labs, Inc. announced that it has obtained the complete assignment interest in its patent on advanced dental implant technology, thereby enabling commercialization to proceed unencumbered. This supports Sigma Labs' exclusive marketing agreement (EMA) with Manhattan Scientifics, Inc. The EMA sets forth the parties' intent to market Sigma Labs technology to prospective licensees and strategic partners. The Sigma Labs rapid healing implant uses former U.S. National Laboratory technology to create a surface that can completely integrate with bone in four to six weeks, with attendent reduction of inflamation and patient discomfort. Mark Cola, President and Chief Executive Officer of Sigma Labs, stated, "In an continuing effort to monetize our full IP portfolio while maintaining focus on our efforts in PrintRite3D for metal 3D printing, we are pleased to work with Manhattan Scientifics to identify prospective licensees and strategic partners for our advanced dental implant technology." To read the entire article, click here.